Growth-stimulating effect of ferric citrate on hybridoma cells: characterization and relation to transferrin function
Language English Country United States Media print
Document type Journal Article
PubMed
3397072
DOI
10.1089/hyb.1988.7.255
Knihovny.cz E-resources
- MeSH
- Species Specificity MeSH
- Hybridomas drug effects MeSH
- Humans MeSH
- Mice MeSH
- Swine MeSH
- Growth Substances pharmacology MeSH
- Cattle MeSH
- Transferrin physiology MeSH
- Ferric Compounds pharmacology MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Mice MeSH
- Cattle MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- ferric citrate MeSH Browser
- Growth Substances MeSH
- Transferrin MeSH
- Ferric Compounds MeSH
The growth of mouse hybridomas in the defined medium with ferric citrate at the optimum growth-stimulating concentration of 500 microM in place of transferrin is fully comparable with the growth in the medium with transferrin at the optimum concentration of 5 micrograms/ml. Experiments with monoclonal antibody to mouse transferrin receptor demonstrate that the growth-stimulating effect of ferric citrate is not based on the action of residual transferrin or the action of transferrin secreted by hybridoma cells. Such growth-stimulating effect is specific for iron compounds while other metal trace elements are ineffective. Hybridoma cells can absorb iron from medium containing iron salt without the presence of transferrin.
References provided by Crossref.org
Iron deprivation induces apoptosis independently of p53 in human and murine tumour cells
Differing sensitivity of tumor cells to apoptosis induced by iron deprivation in vitro